clotrimazole has been researched along with nitroarginine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Fulton, D; McGiff, JC; Quilley, J | 1 |
Davis, SC; Edwards, G; Högestätt, ED; Weston, AH; Zygmunt, PM | 1 |
Fujimoto, S; Itoh, T | 1 |
Brooks, LA; Dellsperger, KC; Fudge, JL; Weintraub, NL; Widmann, MD | 1 |
Qiu, Y; Quilley, J | 1 |
Chen, J; Fu, CY; Han, M; Long, Y; Tian, XZ; Wang, R | 1 |
7 other study(ies) available for clotrimazole and nitroarginine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetylcholine; Animals; Arginine; Blood Pressure; Body Weight; Bradykinin; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Nitric Oxide; Nitroarginine; Oxazines; Rats; Rats, Wistar; Renal Circulation; Vasodilator Agents | 1992 |
Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery.
Topics: Acetylcholine; Animals; Benzopyrans; Biological Factors; Clotrimazole; Cromakalim; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Female; Hepatic Artery; Indomethacin; Membrane Potentials; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Potassium Channels; Proadifen; Pyrroles; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1996 |
Role of nitric oxide and nitric oxide-independent relaxing factor in contraction and relaxation of rabbit blood vessels.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Blood Vessels; Clotrimazole; Cytochrome P-450 Enzyme Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Nitroprusside; Rabbits; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vasodilator Agents | 1997 |
Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo.
Topics: Acetylcholine; Animals; Arachidonic Acid; Arterioles; Clotrimazole; Coronary Circulation; Cytochrome P-450 Enzyme System; Dogs; Enzyme Inhibitors; Fatty Acids, Unsaturated; Female; Male; Muscle, Smooth, Vascular; Nitroarginine; Nitroprusside; Vasodilation; Ventricular Function, Left | 1998 |
K(+)-induced vasodilation in the rat kidney is dependent on the endothelium and activation of K+ channels.
Topics: Animals; Barium Compounds; Bradykinin; Carbenoxolone; Chlorides; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Endothelium; Glyburide; Indomethacin; Kidney; Male; Muscle Contraction; Nitric Oxide; Nitroarginine; Nitroprusside; Phenylephrine; Potassium; Potassium Channels; Prostaglandins; Rats; Rats, Wistar; Tetraethylammonium | 2005 |
Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: roles of potassium ion and nitric oxide.
Topics: Animals; Anti-Infective Agents, Local; Clotrimazole; Coronary Vessels; Dequalinium; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Nitric Oxide; Nitroarginine; Oxadiazoles; Piperidines; Potassium; Potassium Channel Blockers; Protein Precursors; Quinoxalines; Quinuclidines; Rats; Receptors, Neurokinin-1; Receptors, Prostaglandin; Substance P; Swine; Tachykinins; Tetraethylammonium; Vasodilation | 2007 |